Low RNA disruption during neoadjuvant chemotherapy predicts pathologic complete response absence in patients with breast cancer

  1. Cazzaniga, M.E.
  2. Ademuyiwa, F.
  3. Petit, T.
  4. Tio, J.
  5. Generali, D.
  6. Ciruelos, E.M.
  7. Califaretti, N.
  8. Poirier, B.
  9. Ardizzoia, A.
  10. Dr Med, A.H.
  11. Dr Med, B.L.
  12. Mouret-Reynier, M.-A.
  13. Dr Med, D.G.
  14. Isambert, N.
  15. Masetti, R.
  16. Pitre, L.
  17. Dr Med, D.W.
  18. Augereau, P.
  19. Milani, M.
  20. Rask, S.
  21. Dr Med, C.S.
  22. Pritzker, L.
  23. Noubir, S.
  24. Parissenti, A.
  25. Trudeau, M.E.
Aldizkaria:
JNCI Cancer Spectrum

ISSN: 2515-5091

Argitalpen urtea: 2024

Alea: 8

Zenbakia: 1

Mota: Artikulua

DOI: 10.1093/JNCICS/PKAD107 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus